SC 13D/A

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 1)*

 

 

Sucampo Pharmaceuticals, Inc.

(Name of Issuer)

Class A Common Stock, par value $0.01

(Title of Class of Securities)

864909106

(CUSIP Number)

David N. Oakey, Esquire

McGuireWoods LLP

800 East Canal Street

Richmond, VA 23219

(804) 775-1022

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

June 12, 2017

(Date of event which requires filing of this statement)

 

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because § 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g) check the following box  ☐.

 

 

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

 

 

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.

 

 

 


  1   

NAMES OF REPORTING PERSONS.

Sachiko Kuno Foundation, Inc.

 

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).

47-3532147

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)  ☐        (b)  ☐

 

  3  

SEC USE ONLY

 

  4  

SOURCE OF FUNDS

 

OO

  5  

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)  ☐

 

  6  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Maryland

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

 

     7    

SOLE VOTING POWER

 

1,215,860

     8   

SHARED VOTING POWER

 

0

     9   

SOLE DISPOSITIVE POWER

 

1,215,860

   10   

SHARED DISPOSITIVE POWER

 

0

11  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

1,215,860

12  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES  ☐

 

13  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

2.6%

14  

TYPE OF REPORTING PERSON

 

CO


Explanatory Note: This Amendment No. 1 amends and supplements the Schedule 13D originally filed by the undersigned with the Securities and Exchange Commission on December 29, 2016 (the “Original filing”). Capitalized terms used in this Amendment No. 1 and not defined herein have the respective meanings assigned to such terms in the Schedule 13D.

 

Item 4. Purpose of Transaction.

Item 4 is hereby amended and restated as follows:

The Foundation has no present plans or proposals which relate to, or would result in, any one or more of the matters described in subparagraphs (a) through (j) of Item 4 of Schedule 13D, but does reserve the right to, from time to time, acquire or dispose of Shares.

Sachiko Kuno (“Dr. Kuno”), the Foundation’s sole director and President, serves as manager and President of SK Impact Fund, LLC (the “LLC”), which currently holds approximately 15% of the outstanding Shares. The LLC’s sole member is the Trust, for which Dr. Kuno serves as trustee. Kei Tolliver, the Foundation’s Secretary and Treasurer also serves as Secretary and Treasurer of the LLC. Given its status as a significant shareholder, representatives of the LLC may, from time to time, engage in discussions with the Issuer regarding the Issuer’s corporate strategy and general business activities.

 

Item 5. Interest in Securities of the Issuer.

Item 5 is hereby amended and restated as follows:

 

  (a) As of the date hereof, the Foundation beneficially owns 1,215,860 Shares, which represents approximately 2.6% of the outstanding Shares. This percentage calculation is based on the total number of Shares reported as outstanding in the Quarterly Report on Form 10-Q filed by the Issuer with the Securities and Exchange Commission on August 2, 2017. The number and percentage of Shares beneficially owned by the Listed Persons is set forth on Schedule A and is incorporated herein by reference.

 

  (b) The Foundation has sole voting and dispositive power with regard to the Shares described in Item 5(a) above. The nature of the Listed Person’s beneficial ownership of Shares is set forth on Schedule A and is incorporated herein by reference.

 

  (c) A list of transactions engaged in by the Foundation since the Original Filing is set forth on Schedule B attached hereto and is incorporated herein by reference. Any transactions engaged in by the Listed Persons since the Original Filing are described on Schedule A and incorporated herein by reference.

 

  (d) Not applicable.

 

  (e) The Foundation ceased to be the beneficial owner of more than five percent of the Shares as of May 24, 2017.

 

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.

Item 6 is hereby amended and restated as follows:

Not applicable.

 

Item 7. Material to Be Filed as Exhibits.

Item 7 is hereby amended and restated as follows:

Not applicable.


SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: September 27, 2017

 

SACHIKO KUNO FOUNDATION, INC.

By:  

/s/ Sachiko Kuno

Name: Sachiko Kuno

Title: President


Schedule A

 

Name

  

Position and Present Principal Occupation

   Shares Beneficially
Owned
 

Dr. Sachiko Kuno

  

Director and President, Sachiko Kuno Foundation, Inc.

Manager and President, SK Impact Fund, LLC

     8,353,204 1 

Kei Tolliver

  

Secretary and Treasurer, Sachiko Kuno Foundation, Inc.

Founder, Kei S. Tolliver Law, LLC

     1,800 2 

Dr. Kuno is a citizen of the United States and Ms. Tolliver is a citizen of Japan.

The principal business address for each of the persons listed above is c/o Sachiko Kuno Foundation, Inc., 28307 Mallard Drive, Easton, Maryland 21601.

 

  1. Represents approximately 17.9% of the outstanding Shares. Includes 7,137,344 Shares held by the LLC. Also includes 1,215,860 Shares held by the Foundation. Dr. Kuno disclaims beneficial ownership of the shares held by the Foundation.

 

  2. Represents less than 1% of the outstanding Shares. All 1,800 Shares are held directly by Ms. Tolliver.

Transactions by Listed Persons since Original Filing

On September 11, 2017, the LLC, for which Dr. Kuno serves as manager and President, sold 1,000,000 Shares for $12.00 per share through a block trade pursuant to Rule 144 under the Securities Act of 1933, as amended.

Ms. Tolliver has not engaged in any transactions in Shares since the Original Filing.


Schedule B

 

Reporting Person

   Date     

Transaction

   Number of Shares      Price Per Share     

Nature of Transaction

Foundation

     09/01/2017      Sale      19,533      $ 11.8178      Open market sale

Foundation

     08/31/2017      Sale      19,200      $ 11.6202      Open market sale

Foundation

     08/30/2017      Sale      19,540      $ 11.4561      Open market sale

Foundation

     08/29/2017      Sale      16,300      $ 11.3333      Open market sale

Foundation

     08/28/2017      Sale      16,920      $ 11.3378      Open market sale

Foundation

     08/25/2017      Sale      28,000      $ 11.2786      Open market sale

Foundation

     08/24/2017      Sale      17,000      $ 11.2094      Open market sale

Foundation

     08/23/2017      Sale      17,028      $ 11.2172      Open market sale

Foundation

     08/22/2017      Sale      32,436      $ 11.1079      Open market sale

Foundation

     08/21/2017      Sale      77,842      $ 11.0206      Open market sale

Foundation

     08/16/2017      Sale      2,000      $ 10.5125      Open market sale

Foundation

     08/15/2017      Sale      3,488      $ 10.5022      Open market sale

Foundation

     08/14/2017      Sale      1,601      $ 10.5125      Open market sale

Foundation

     08/09/2017      Sale      18,200      $ 10.6007      Open market sale

Foundation

     08/08/2017      Sale      25,102      $ 10.6345      Open market sale

Foundation

     08/07/2017      Sale      2,900      $ 10.5000      Open market sale

Foundation

     08/04/2017      Sale      15,168      $ 10.5450      Open market sale

Foundation

     08/03/2017      Sale      1,962      $ 10.5300      Open market sale

Foundation

     08/02/2017      Sale      7,220      $ 10.7098      Open market sale

Foundation

     08/01/2017      Sale      18,716      $ 10.6725      Open market sale

Foundation

     07/31/2017      Sale      9,400      $ 10.8024      Open market sale

Foundation

     07/28/2017      Sale      15,800      $ 10.8419      Open market sale

Foundation

     07/27/2017      Sale      26,805      $ 10.7892      Open market sale

Foundation

     07/26/2017      Sale      12,315      $ 11.0267      Open market sale

Foundation

     07/25/2017      Sale      13,476      $ 11.0048      Open market sale

Foundation

     07/24/2017      Sale      10,315      $ 10.9452      Open market sale

Foundation

     07/21/2017      Sale      7,090      $ 10.9073      Open market sale

Foundation

     07/20/2017      Sale      15,900      $ 10.9566      Open market sale

Foundation

     07/19/2017      Sale      20,827      $ 10.8519      Open market sale

Foundation

     07/18/2017      Sale      13,100      $ 10.8721      Open market sale

Foundation

     07/17/2017      Sale      19,900      $ 10.9671      Open market sale

Foundation

     07/14/2017      Sale      23,778      $ 11.0110      Open market sale

Foundation

     07/13/2017      Sale      19,074      $ 10.9346      Open market sale

Foundation

     07/12/2017      Sale      18,276      $ 10.7834      Open market sale

Foundation

     07/11/2017      Sale      31,400      $ 10.7688      Open market sale

Foundation

     07/10/2017      Sale      20,300      $ 10.7116      Open market sale

Foundation

     07/07/2017      Sale      10,541      $ 10.6285      Open market sale

Foundation

     07/06/2017      Sale      6,800      $ 10.5408      Open market sale

Foundation

     07/05/2017      Sale      17,884      $ 10.6043      Open market sale

Foundation

     07/03/2017      Sale      8,105      $ 10.6249      Open market sale

Foundation

     06/30/2017      Sale      4,100      $ 10.5244      Open market sale

Foundation

     06/29/2017      Sale      11,266      $ 10.5576      Open market sale

Foundation

     06/28/2017      Sale      7,430      $ 10.5831      Open market sale

Foundation

     06/27/2017      Sale      10,700      $ 10.4925      Open market sale

Foundation

     06/12/2017      Sale      7,900      $ 10.0206      Open market sale

Foundation

     06/09/2017      Sale      16,120      $ 10.1489      Open market sale

Foundation

     06/08/2017      Sale      8,590      $ 10.0725      Open market sale

Foundation

     06/07/2017      Sale      8,337      $ 10.0293      Open market sale

Foundation

     06/06/2017      Sale      14,805      $ 10.0570      Open market sale

Foundation

     06/05/2017      Sale      18,724      $ 10.0340      Open market sale

Foundation

     06/02/2017      Sale      11,859      $ 10.3527      Open market sale

Foundation

     05/30/2017      Sale      59,303      $ 10.0496      Open market sale

Foundation

     05/26/2017      Sale      25,019      $ 10.2931      Open market sale

Foundation

     05/25/2017      Sale      45,000      $ 10.4356      Open market sale

Foundation

     05/24/2017      Sale      180,283      $ 10.6696      Open market sale

Foundation

     05/23/2017      Sale      73,745      $ 10.4944      Open market sale